Inhaled Corticosteroids, Bone Mineral Density and Fracture in Older People

被引:0
作者
Richard Hubbard
Anne Tattersfield
机构
[1] University of Nottingham,Division of Respiratory Medicine
[2] University of Nottingham,City Hospital
来源
Drugs & Aging | 2004年 / 21卷
关键词
Asthma; Bone Mineral Density; Corticosteroid; Chronic Obstructive Pulmonary Disease; Fracture Risk;
D O I
暂无
中图分类号
学科分类号
摘要
The efficacy of inhaled corticosteroids in the treatment of asthma has been firmly established in a variety of settings. The majority of asthma management plans now recommend the use of inhaled corticosteroids at an early stage. This means that most patients with asthma will be prescribed an inhaled corticosteroid at some point in time and many patients with asthma will use these drugs for several years.
引用
收藏
页码:631 / 638
页数:7
相关论文
共 171 条
[1]  
Brown HM(1972)Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma BMJ I 585-90
[2]  
Storey G(1972)Effect of beclomethasone dipropionate delivered by aerosol in patients with asthma Lancet I 1361-4
[3]  
George WH(1975)Inhaled corticosteroids compared with oral prednisolone in patients starting long term corticosteroid therapy for asthma Lancet II 469-73
[4]  
Clark TJH(1973)Recovery of adrenal function after substitution of beclomethasone dipropionate for oral corticosteroids BMJ I 778-82
[5]  
Maberly DJ(1991)Comparison of beta-2 agonist terbutaline with an inhaled corticosteroid budesonide in newly detected asthma N Engl J Med 325 338-92
[6]  
Gibson GJ(1997)Effect of inhaled formoterol and budesonide on exacerbations of asthma N Engl J Med 337 1405-11
[7]  
Butler AG(2003)Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial Lancet 361 1071-6
[8]  
Haahtela T(1997)Physician diagnosed asthma and drug utilisation in the European Community Respiratory Health Survey Eur Respir J 10 1795-802
[9]  
Jarvinen M(1994)Which patients are prescribed inhaled anti-asthma drugs? Thorax 49 1090-5
[10]  
Kava T(2000)Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial BMJ 320 1297-303